Hillier et al, The Wash U-Merck EST Project, Accession #R91733.* |
Hillier et al, The Wash U-Merck EST Project, Accession #R98668.* |
Hillier et al, The Wash U-Merck EST Project Accession #H62013.* |
Hillier et al, The Wash U-Merck EST Project Accession #H54642.* |
GenBank accession No. AAK49027, May 02, 2001.* |
Pardigol et al., PNAS 95:6308-6313, May 1998.* |
Sticht et al. Biochemistry 38(5995-6002)1999.* |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25941, citing: WO 9721812 A2 dated 970619; US 95-567882 dated 951208; “Search record pertaining to mouse CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W07202, citing: WO 9634891 A1 dated 961107; US 95-446881 dated 950505; “Search record pertaining t mouse CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W05186, citing: WO 9632481 A1 dated 961017; US 95-42114 dated 950413; “Search record pertaining to mouse CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W38170, citing: WO 9741230 A2 dated 971106 ; DE 96-19617312 dated 960430; “Search record pertaining to mouse CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25942; citing; WO 9721812 A2 dated 970619; US 95-567882 dated 951208; “Search record pertaining to mouse CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W38170, citing: WO 9741230 A2 dated 971106; DE 96-19617312, dated 960430; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25942, citing: WO 9721812 A2 dated 970619; US 95-567882, dated 951208; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W07202, citing: WO 9634891 A1 dated 961107; US 95-446881, dated 950505; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W05186, citing: WO 9632481 A1 dated 961017; US 95-421144, dated 950413; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 95P-R76126, citing: WO 9517092 A1 dated 950629; US 94-208339, dated 940308; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W17663, citing: WO 9715594 A1 dated 970501; US 95-6051, dated 951024; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W16315, citing: WO 9712041 A1 dated 970403; US 95-4517, dated 950929; “Search record pertaining to human CCF-18, performed in Jul. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W31850, citing: WO 9741154 A1 dated 971106; Patent GB 97-894 dated 970117; US 96-16158 dated 960426; US 96-17113 Dated 960426; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W27124, citing: WO 9722698 A2 dated 970626; US 96-661393 dated 960607; US 95-575967 dated 951220; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25943, citing: WO 9721812 A2 dated 970619; US 95-567882 dated 951208 “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W10100, citing: WO 9700960 A1 dated 970109; US 95-494093 Date 950623; “Search record pertaining to CCR3 (segment 1), performed on Jun. 28, 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03378, citing: WO 9622371 A2 dated 960725; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03377 citing: WO 9622371 A2 date 960725; Patent US 95-375199 Date 950119; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03376, citing: WO 9622371 A2 dated 960725; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W26588, citing: US 5652133 A dated 970729; US 93-12988 dated 930128; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25751, citing: JP 09176048 A dated 970708; and JP 95-342130 dated 951228; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 94P-R52749, citing: WO 9411504 A dated 940526; WO 93-U100672 dated 931104; US 92-974025 dated 921110; “Search record pertaining to CCR3 (segment 1), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P W25943, citing: WO 9721812 A2 dated 970619; WO 96-US19139 dated 961205; US 95-567882 dated 951208; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W31850, citing: WO 9741154 A1 dated 971106; WO 97-US6568 dated 970424; GB 97-894 dated 970117; US 96-16158 dated 960426; US 96-17113 dated 960426; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W27124, citing: WO 9722698 A2 dated 970626; WO 96-U200759 dated 961220; US 96-661393 dated 960607; US 95-575967 dated 951220; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03377, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P W10100, citing: WO 9700960 A1 dated 970109; WO 96-US10723 dated 960621; 95-494093 dated 950623; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03376, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03378, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W26588, citing: US 5652133 A dated 970729; US 93-12988 dated 930128; US 93-12988 dated 930128; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25751, citing: JP 09176048 A dated 970708; JP 95-342130 dated 951228; JP 95-342130 dated 951228; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 94P-R52749, citing: WO 9411504 A dated 940526; WO 93-U100672 dated 931104; US 92-974025 dated 921110; “Search record pertaining to CCR3 (segment 2), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W31850, citing: WO 9741154 A1 dated 971106; WO 97-US6568 dated 970424; GB 97-894 dated 970117; US 96-16158 dated 960426; US 96-17113 dated 960426; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W27124, citing: WO 9722698 A2 dated 970626; WO 96-U200759 dated 961220; US 96-661393 dated 960607; US 95-575967 dated 951220; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25943, citing: WO 9721812 A2 dated 970619; WO 96-US19139 dated 961205; US 95-567882 dated 951208; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W10100, citing: WO 9700960 A1 dated 970109; WO 96-US10723 dated 960621; US 95-494093 dated 950623; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03377, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03376, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 96P-W03378, citing: WO 9622371 A2 dated 960725; WO 96-US608 dated 960119; US 95-375199 dated 950119; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W26588, citing: US 5652133 A dated 970729; US 93-12988 dated 930128; US 93-12988 dated 930128; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W25751, citing: JP 09176048 A dated 970708; JP 95-342130 dated 951228; JP 95-342130 dated 951228; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Derwent Geneseq Patent Sequence Database, Accession No. 94P-R52749, citing: WO 9411504 A dated 940526; WO 93-U100672 dated 931104; US 92-974025 dated 921110; “Search record pertaining to CCR3 (segment 3), performed in Jun. 1998”. |
Hara et al., Molecular Cloning and Functional Characterization of a Novel Member of the C-C Chemokine Family, The Journal of Immunology, 1995, 5352-5358, 155. |
pg,12 |
Kevin B. Bacon, et al., “IL-8-Induced Signal Transduction in T Lymphocytes Involves Receptor-Mediated Activation of Phospholipases C and D,” J. Immunol. 154:3654-3666, 1995. |
K. B. Bacon, et al., “Contrasting in vitro Lymphocyte Chemotactic Activity of the Hydroxy; Enatiomers of 12-Hydroxy-5,8,10,14-Eicosatetraenoic Acid,” Br. J. Pharmacol. 95:966-974, 1988. |
Mark S. Berger, et al., “The Gene for C10, a Member of the β-Chemokine Family, Is Located on Mouse Chromosome 11 and Contains a Novel Second Exon Not Found in Other Chemokines,” DNA and Cell Biol. 12:839-847, 1993. |
Michael J. Berridge, “Inositol Triphosphate and Calcium Signalling,” Nature 361:315-325, Jan. 28, 1993. |
M. Motasim Billah, et al., “The Regulation and Cellular Functions of Phosphatidylcholine Hydrolysis,” Biochem. J. 269:281-291, 1990. |
Theodore M. Danoff, et al., “Cloning, Genomic Organization, and Chromosomal Localization of the Scya5 Gene Encoding the Murine Chemokine RANTES,” J. Immunol. 152:1182-1189, 1994. |
Angela M. Gronenborn, et al., “Modeling the Three-Dimensional Structure of the Monocyte Chemo-Attractant and Activating Protein MCAF/MCP-1 on the Basis of the Solution Structure of Interleukin-8,” Prot. Engg. 4:263-269, 1991. |
Takahiko Hara, et al., “Molecular Cloning and Functional Characterization of a Novel Member of the C-C Chemokine Family,” J. Immunol. 155:5352-5358, 1995. |
Gregory S. Kelner, et al., “Lymphotactin: A Cytokine That Represents a New Class of Chemokine,” Science 266:1395-1399, Nov. 23, 1994. |
Patrica J. Lodi, et al., “High-Resolution Solution Structure of the β Chemokine hMIP-1β by Multidimensional NMR,” Science, 263:1762-1767, Mar. 25, 1994. |
Kouji Matsushima, et al., “Interleukin 8 and MCAF: Novel Inflammatory Cytokines Inducible by IL 1 and TNF,” Cytokine 1:2-13, Nov. 1989. |
Michael D. Miller, et al., “The Human Cytokine I-309 Is a Monocyte Chemoattractant,” Proc. Natl. Acad. Sci 89:2950-2954, 1992. |
Michael D. Miller, et al., “Biology and Biochemistry of the Chemokines: A Family of Chemotactic and Inflammatory Cytokines,” Crt. Rev. Immunol. 12:17-46, 1992. |
Joost J. Oppenheim, et al., “Properties of the Novel Proinflammatory Supergene ‘Intercrine’ Cytokine Family,” Ann. Rev. Immunol. 9:617-548, 1991. |
Amos Orlofsky, et al., “Selective Induction of the β Chemokine C10 by IL-4 in Mouse Macrophages,” J. Immunol. 154:5084-5091, 1994. |
Thomas J. Schall, “The Chemokines,” The Cytokine Handbook, 2d ed., Academic Press, pp 419-460, 1994. |
Thomas J. Schall, et al., “Chemokines, Leukocyte Trafficking, and Inflammation,” Curr. Opin. Immunol. 6:865-873, 1994. |
Thomas J. Schall, “Biology of the RANTES/SIS Cytokine Family,” Cytokine 3:165-183, May 1991. |
Thomas J. Schall, et al., “Human Macrophage Inflammatory Protein α (MIP-1α) and MIP-1β Chemokines Attract Distinct Populations of Lymphocytes,” J. Exp. Med. 177:1821-1825, Jun. 1993. |
Mark Y Stoeckle, et al. “Two Burgeoning Families of Platelet Factor 4-Regulated Proteins: Mediators of the Inflammatory Response,” The New Biologist 2:313-323, Apr. 1990. |
Stephen D. Wilson, et al., “Clustering of Cytokine Genes on Mouse Chromosome 11,” J. Exp. Med. 171:1301-1314, Apr. 1990. |
Kuldeep Neote, et al., “Molecular Cloning, Functional Expression, and Signalling Characteristics of a C-C Chemokine Receptor,” Cell 72:415-425, Feb. 12, 1993. |
A.N. Poltorak, et al., Journal of Inflammation, 45:207-219, 1995. “MIP-1γ: Molecular Cloning, Expression, and Biological Activities of a Novel CC Chemokine That Is Constitutively Secreted In Vivo”. |
Christophe Combadiere, et al., J Biological Chemistry, 270(27):16491-16494, 1995. “Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor”. |
L. Hillier, et al., EMBL Database Entry HS733189; Accession No. R91733, Aug. 28, 1995. “The WashU-Merck EST Project”. |
A. N. Poltorak, et al., Journal of Investigative Medicine, (Suppl. 2):364A, 1995. “MIP-1γ: A Novel Neutrophil-Activating, Pyrogenic CC Chemokine that Circulates in Plasma at Pharmacologically Active Concentrations”. |
A. Poltorak, et al., Clinical Research, 42(2):306A, 1994. “Molecular Cloning of MIP-γ A New Member of the Chemokine Family through Differential Screening Based on Extinction of Macrophage-Specific Genes”. |
Youn, Byung-S, et al., “A Novel Chemokine, Macrophage Inflammatory Protein-Related Protein-2, Inhibits Colony Formation of Bone Marrow Myeloid Progenitors,” The American Assoc. of Immunologists, pp. 2661-2667 (Sep. 1, 1995). |